Clinical trials
Phase 2 Myelodysplastic Syndromes trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| National Cancer Institute (NCI) | 4 |
| Celgene | 2 |
| Kiadis Pharma | 2 |
| Mirati Therapeutics Inc. | 2 |
| Sunnybrook Health Sciences Centre | 2 |
| University of Manitoba | 2 |
| Children's Oncology Group | 1 |
| Eisai Inc. | 1 |
| Forma Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 34 |
| Leukemia, Myeloid, Acute | 12 |
| Leukemia, Myelomonocytic, Chronic | 8 |
| Myeloproliferative Disorders | 6 |
| Anemia, Refractory, with Excess of Blasts | 5 |
| Myelodysplastic-Myeloproliferative Diseases | 5 |
| Hematologic Neoplasms | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia, Refractory | 2 |
| Graft vs Host Disease | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.